Nonpathogenic intestinal amebae infection epidemiology and demographics

Nonpathogenic intestinal amebae infection Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Nonpathogenic intestinal amebae infection from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Treatment
Medical Therapy
Case Studies
Case #1
Nonpathogenic intestinal amebae infection epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Nonpathogenic intestinal amebae infection epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Nonpathogenic intestinal amebae infection epidemiology and demographics
CDC on Nonpathogenic intestinal amebae infection epidemiology and demographics
Nonpathogenic intestinal amebae infection epidemiology and demographics in the news
Blogs on Nonpathogenic intestinal amebae infection epidemiology and demographics
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Nonpathogenic intestinal amebae infection epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

The species that are nonpathogenic (Chilomastix mesnili, Endolimax nana, Entamoeba coli, Entamoeba dispar, Entamoeba hartmanni, Entamoeba polecki, Iodamoeba buetschlii) are distributed worldwide. Consequently, infections by these species occur worldwide. Entamoeba polecki in nature is primarily a parasite of pigs and monkeys, and human infection is more prevalent in areas where the people have animal contact.

References

Template:WikiDoc Sources